Castle Biosciences (CSTL) Acquisitions (2022)

Castle Biosciences (CSTL) posted Acquisitions of $305000.0 for Q3 2022.

Castle Biosciences (CSTL) Acquisitions (2022) Analysis & Trends

Castle Biosciences (CSTL) has 1 years of Acquisitions data on file, last reported at $305000.0 in Q3 2022.

  • Quarterly Acquisitions changed N/A year-over-year to $305000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2023 was $305000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $27.0 million, changed N/A from the prior year.
  • Acquisitions held at $305000.0 in Q3 2022 per CSTL's latest filing.
  • The five-year high for Acquisitions was $305000.0 in Q3 2022, with the low at $305000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 144.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 8.87 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 37.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 415.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 2.24 Mn
10 Castle Biosciences 738.56 Mn 476.84 Mn 63.15 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 305,000.00